The Centers for Disease Control (CDC) yesterday announced that it would make 200,000 doses of a protein-based Novavax vaccine ...

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...

Settling royalty disputes and acquiring Biotheus, BioNTech reshapes its future in vaccines and oncology innovation.

BioNTech SE ( (BNTX) ) has provided an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street ...

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further ...

By learning lessons from other sectors, public health can ensure it is ready to face future outbreaks in record time.

Tokyo-headquartered pharmaceutical company, Meiji Seika Pharma has filed a lawsuit against Kazuhiro Haraguchi, a Lower House member of Japan’s Constitutional Democratic Party, for reportedly spreading ...

This year's winter COVID-19 wave is off to a late start, and experts expect cases to keep rising. Here's what to know.

Across 2024, more than 4,940 workers lost their jobs at Massachusetts life sciences companies. The Business Journal has a ...

With global markets experiencing volatility amid cautious Federal Reserve commentary and political uncertainty, investors are closely monitoring opportunities that can offer potential value. In this ...

Of the top news articles, Vertex Pharmaceuticals' suzetrigine garnered much attention as it's a promising new class of pain ...